MESWANI PARAG V

PrivateCIK: 1909324
Location

NEW YORK, NY

MESWANI PARAG V enters SIO GENE THERAPIES INC. with 33.73K shares plus derivative instruments

Holding both equity and derivatives at entry signals strong long-term conviction in the company.

Direct Derivatives
InsiderMESWANI PARAG VCIK 1909324
IssuerSIO GENE THERAPIES INC.CIK 1636050
Officer· Chief Commercial Officer
Since Jan 2022
33.73K
Baseline shares
100% direct
33.73K
Direct ownership
1 position
335.07K
Derivative underlying
8 instruments
1
Security positions
All direct
Non-Derivative Holdings1

Common Stock

Direct
Shares owned33.73K
Total
33.73K direct33.73K
Derivative Holdings8

Stock Option (Right to Buy)

Direct
Underlying security
Common Stock

Underlying shares

15.63K

Shares owned

N/A

Exercise price

9.2

Expiration

Exercise window

Restricted Stock Units

Direct
Underlying security
Common Stock

Underlying shares

25.33K

Shares owned

N/A

Exercise price

Expiration

Exercise window

Stock Option (Right to Buy)

Direct
Underlying security
Common Stock

Underlying shares

20.88K

Shares owned

N/A

Exercise price

8.48

Expiration

Exercise window

Restricted Stock Units

Direct
Underlying security
Common Stock

Underlying shares

8.03K

Shares owned

N/A

Exercise price

Expiration

Exercise window

Stock Option (Right to Buy)

Direct
Underlying security
Common Stock

Underlying shares

18.07K

Shares owned

N/A

Exercise price

5.63

Expiration

Exercise window

Stock Option (Right to Buy)

Direct
Underlying security
Common Stock

Underlying shares

15.63K

Shares owned

N/A

Exercise price

9.2

Expiration

Exercise window

Stock Option (Right to Buy)

Direct
Underlying security
Common Stock

Underlying shares

219K

Shares owned

N/A

Exercise price

2.47

Expiration

Exercise window

Stock Option (Right to Buy)

Direct
Underlying security
Common Stock

Underlying shares

12.50K

Shares owned

N/A

Exercise price

8.48

Expiration

Exercise window

Total

Underlying

335.07K

Owned

0.00

MESWANI PARAG V — Initial Ownership Disclosure (Form 3) Filed Feb 7, 2022 | Finecho